Compare MYGN & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MYGN | AVNS |
|---|---|---|
| Founded | 1991 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 481.6M | 521.7M |
| IPO Year | 1996 | 2014 |
| Metric | MYGN | AVNS |
|---|---|---|
| Price | $4.65 | $13.08 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $7.64 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 583.1K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.59 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $771,400,000.00 | $701,200,000.00 |
| Revenue This Year | $7.19 | $3.28 |
| Revenue Next Year | $5.64 | $4.23 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 2.33 | 1.95 |
| 52 Week Low | $3.76 | $9.30 |
| 52 Week High | $10.25 | $15.68 |
| Indicator | MYGN | AVNS |
|---|---|---|
| Relative Strength Index (RSI) | 42.83 | 40.25 |
| Support Level | $3.93 | $12.75 |
| Resistance Level | $5.63 | $13.11 |
| Average True Range (ATR) | 0.33 | 0.51 |
| MACD | 0.00 | -0.08 |
| Stochastic Oscillator | 23.53 | 22.70 |
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.